703 Main St, St. Joseph's Regional Medical Center, 
Paterson, NJ 

Overview

Mary Bonilla is a Pediatric Hematologist Oncology provider in Paterson, New Jersey. Dr. Bonilla is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Leukemia, Acute Lymphoblastic Leukemia (ALL), Adult Soft Tissue Sarcoma, and Embryonal Tumor with Multilayered Rosettes.

Her clinical research consists of co-authoring 2 peer reviewed articles and participating in 28 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in NJ
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

703 Main St, St. Joseph's Regional Medical Center, Paterson, NJ 07503

Additional Areas of Focus

Dr. Bonilla has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


28 Clinical Trials

Umbrella Long-Term Follow-Up Protocol
Neuroblastoma Biology Studies
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
Renal Tumors Classification, Biology, and Banking Study
Key Adverse Events After Childhood Cancer
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
View 25 Less Clinical Trials
Similar Doctors
Elite in Immune Thrombocytopenic Purpura (ITP)
Pediatric Hematology Oncology
Elite in Immune Thrombocytopenic Purpura (ITP)
Pediatric Hematology Oncology
525 E 68th St # P-695, 
New York, NY 
 (14.6 miles away)
Languages Spoken:
English

James Bussel is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Bussel is rated as a Distinguished provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Immune Thrombocytopenic Purpura (ITP), Blood Clots, Anemia, Hemolysis, and Splenectomy.

Advanced in Immune Thrombocytopenic Purpura (ITP)
Pediatric Hematology Oncology
Advanced in Immune Thrombocytopenic Purpura (ITP)
Pediatric Hematology Oncology
948 48th St, 
Brooklyn, NY 
 (20.1 miles away)
Languages Spoken:
English

Shipra Kaicker is a Pediatric Hematologist Oncology provider in Brooklyn, New York. Dr. Kaicker is rated as an Advanced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Immune Thrombocytopenic Purpura (ITP), Blood Clots, Non-Langerhans-Cell Histiocytosis, and Histiocytosis.

Advanced in Immune Thrombocytopenic Purpura (ITP)
Pediatric Hematology Oncology
Advanced in Immune Thrombocytopenic Purpura (ITP)
Pediatric Hematology Oncology

New York University

160 E 32nd St, 
New York, NY 
 (14.6 miles away)
Languages Spoken:
English

Kirsty Hillier is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Hillier is rated as an Advanced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Immune Thrombocytopenic Purpura (ITP), Blood Clots, Neuroblastoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bonilla's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile